Evidence map›Paper›PMID 42107712›Full record

ArticleJournal of thrombosis and haemostasis : JTH2026

Shear cytokine crosstalk is a determinant of SARS-CoV-2-induced endothelial pathophysiology and thrombosis in human vessel chips.

Sreelakshmy Suresh, Rebecca John, John P Cooke, John H Connor, Abhishek Jain

Abstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sreelakshmy SureshDepartment of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, Texas, USA.
Rebecca JohnDepartment of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, Texas, USA.
John P CookeDepartment of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, Texas, USA.
John H ConnorNational Emerging Infectious Diseases Laboratories, Department of Virology, Immunology, and Microbiology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Abhishek JainDepartment of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, Texas, USA; Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, Texas, USA; Department of Medical Physiology, Naresh K. Vashisht College of Medicine, A&M Health Science Center, Bryan, Texas, USA. Electronic address: a.jain@tamu.edu.

Funding

Determinants of COVID19-induced venous thrombosis and targeted therapy assessed with bioengineered vein-chipR01HL157790 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CONNOR, JOHN H, COOKE, JOHN P · 2021 to 2024
$2.8M
Engineering Oral Tumor Microcirculation: Blood and lymphatic capillary network-enabled Human Oral Tumor Microenvironment Chips for Preclinical ResearchR21DE035321 · NIDCR · TEXAS ENGINEERING EXPERIMENT STATION · PI JAIN, ABHISHEK · 2025 to 2025
$422k
NHLBI NIH HHS R01 HL157790NIDCR NIH HHS R21 DE035321
6 · The paper itself

Abstract

backgroundSARS-CoV-2 infection is associated with systemic vasculopathy and thromboinflammation. However, the interaction between shear-dependent endothelial function, inflammatory signaling, and thrombosis during viral exposure remains incompletely defined due to limitations of conventional in vitro and animal models.

objectivesTo determine how flow modulates endothelial structure, barrier integrity, inflammatory activation, and thrombogenic responses during exposure to SARS-CoV-2 spike protein or the complete virus, with or without interleukin-6 (IL-6).

methodsA human endothelialized vessel chip platform was used to independently control flow (10 dyne/cm

resultsUnder static conditions, spike exposure disrupted endothelial morphology, disorganized intercellular junctions, and increased permeability. Flow mitigated these changes, preserving junctional organization and reducing barrier disruption during viral exposure. IL-6 induced cytoskeletal remodeling and barrier dysfunction, consistent with inflammatory activation. When shear stress, IL-6, and spike exposure were combined, flow preserved junctional architecture and reduced morphological injury, although IL-6-associated cytoskeletal alterations persisted. Flow reduced viral replication, permeability, and thrombotic markers by 40% to 60% compared with static or inflammatory conditions, whereas IL-6 increased these measures. vesicular stomatitis virus-ΔG-Spike and authentic SARS-CoV-2 produced concordant phenotypes across junctional metrics, intercellular adhesion molecule 1 induction, and replication.

conclusionFlow partially preserves endothelial homeostasis during viral and inflammatory challenges, limiting structural injury, viral replication, and thromboinflammatory activation. These findings highlight the vessel chip as a rigorous platform for dissecting flow-dependent vascular pathology.

Indexed as

bioengineeringendotheliummicrophysiological systemSARS-CoV-2thrombosis

Identifiers

PMID42107712
PMCPMC13592030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.